Diaper Rash
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program1
Zinc Oxide Diaper Rash OintmentPhase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GSK0.25 % Miconazole Nitrate Ointment
Johnson & JohnsonZinc Oxide Diaper Rash Ointment
Bausch HealthCeraVe Baby Diaper Rash Cream
Clinical Trials (3)
Total enrollment: 312 patients across 3 trials
Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants
Start: May 2007Est. completion: Dec 2010200 patients
Phase 4Completed
Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash
Start: Jun 2005Est. completion: Oct 2005112 patients
Phase 4Completed
CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Start: Dec 2014Est. completion: Jul 2016
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space